CHRONIC KIDNEY DISEASE IN THE TIME OF COVID-19: OBSERVING PATIENT OUTCOMES IN MUMBAI

Swapnil Pathak

Authors

Swapnil Pathak

Assistant Professor at Rajiv Gandhi Medical College and Chhatrapati Shivaji Maharaj Hospital, Mumbai Maharashtra, India

Keywords

Chronic kidney disease patient outcomes observational study

Abstract

"Chronic Kidney Disease in the Time of COVID-19: Observing Patient Outcomes in Mumbai" investigates the compounded impact of the COVID-19 pandemic on patients suffering from chronic kidney disease (CKD) in Mumbai, one of India’s largest metropolitan areas. This observational study examines the outcomes of CKD patients during the pandemic, focusing on changes in their health status, access to healthcare services, and the unique challenges faced during lockdowns and restricted mobility. The study analyzes data collected from healthcare facilities, including patient records, hospital admissions, and clinical outcomes, to understand the effects of delayed treatment, disruption of dialysis schedules, and the increased risk of COVID-19-related complications in CKD patients. The research also highlights how socioeconomic factors, such as income loss and lack of resources, exacerbated the health struggles of these vulnerable individuals. By documenting these experiences, the study aims to raise awareness of the heightened risks faced by CKD patients during the pandemic and underscores the need for improved healthcare responses to safeguard this high-risk group in future health crises.

Downloads

Download data is not yet available.

References

1

Wu, Z., & McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 323(13), 1239-1242.

2

Flythe, J. E., Assimon, M. M., Tugman, M. J., Chang, E. H., Gupta, S., Shah, J., ... & Sosa, M. A. (2020). Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. American Journal of Kidney Diseases, 76(4), 490-495.

3

Jager, K. J., Kramer, A., Chesnaye, N. C., Couchoud, C., Sánchez-Álvarez, J. E., Garneata, L., ... & Stel, V. S. (2020). Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney International, 98(6), 1540-1548.

4

Khan, I. H., Zahra, S. A., Zaim, S., Harky, A., & At the heart of COVID-19. (2020). Cardiovascular implications and therapeutic considerations. European Journal of Preventive Cardiology, 27(9), 933-946.

5

Hollander, J. E., & Carr, B. G. (2020). Virtually perfect? Telemedicine for Covid-19. New England Journal of Medicine, 382(18), 1679-1681.